Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Cefotaxime Resistance in Treatment of Spontaneous Bacterial Peritonitis

NCT02388035 is registered in ClinicalTrials.gov with Dr Ahmed Ali Elbaz as lead sponsor.

NCT NCT02388035
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02388035 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Cefotaxime Resistance in Treatment of Spontaneous Bacterial Peritonitis
Lead sponsor
Dr Ahmed Ali Elbaz
Phase
Not applicable
Overall status
Completed
Start date
March 31, 2015
Completion date
June 30, 2015
Enrollment
254 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

spontaneous bacterial peritonitis